How Robert F. Kennedy Jr. Wants to Unleash Unregulated Peptide Drugs
The U.S. Health Secretary plans to open up the sale of risky, unproven peptide drugs to the public - undermining science and public health in favor of 'wellness' profiteers.
Robert F. Kennedy Jr., the U.S. Health Secretary, is pushing to make a wide range of injectable peptide drugs available to the public without proper clinical trials or regulation. Peptides are complex molecules that can have powerful effects on the body, but their safety and efficacy must be rigorously tested before being made widely available.
Rather than upholding the precautionary principle and prioritizing public health, Kennedy's Make America Healthy Again (Maha) agenda tends to undermine scientific expertise in favor of unproven 'wellness' treatments and the interests of profiteers. This approach could leave Americans vulnerable to the risks of untested drugs promoted by hucksters and purveyors of misinformation.
Peptides are used by the body to send important signals, and there are many different types with varying effects. The safety and efficacy of each peptide must be individually evaluated through rigorous clinical trials before being made available to the public. Yet Kennedy claims he will open up the sale of about 14 injectable peptide drugs, side-stepping this crucial process.
Source: The Guardian
